Position in GILD
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$8,399,335
-$2,318,636 QoQ
Shares Held
66,482
-13.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#464
of 2,266 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Caprock Group, LLC holds $186,163,406 across 16 Drug Manufacturers - General names. GILD ranks #6 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
68,190 | $81,789,138 | |
| 2 | JNJ |
Johnson & Johnson
|
89,403 | $22,705,679 | |
| 3 | AMGN |
Amgen Inc
|
51,552 | $18,668,010 | |
| 4 | ABBV |
AbbVie Inc.
|
62,909 | $15,830,420 | |
| 5 | MRK |
Merck & Co., Inc.
|
79,617 | $10,230,784 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
66,482 | $8,399,335 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
115,747 | $6,669,342 | |
| 8 | NVS |
Novartis AG
|
39,351 | $6,167,088 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,399,335 | 66,482 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $10,717,971 | 76,903 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $9,442,510 | 76,931 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $7,107,996 | 64,036 | Shares | Sole | 2025-11-06 | |
| 2025-03-31 | $5,540,312 | 49,445 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,913,624 | 42,369 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $3,219,372 | 38,399 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $2,756,543 | 40,177 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $2,043,015 | 27,891 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $2,203,796 | 27,204 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $2,035,670 | 27,164 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $2,230,868 | 28,946 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,349,959 | 28,323 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $2,272,277 | 26,468 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $1,628,677 | 26,401 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,449,938 | 23,458 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $1,211,055 | 20,371 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $1,424,462 | 19,618 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $1,452,321 | 20,792 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $1,561,882 | 22,682 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $798,374 | 12,353 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $483,150 | 8,293 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $882,069 | 13,959 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $2,064,300 | 26,830 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $1,702,210 | 22,769 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||